About: Safety of Same and Next Day Discharge Following Revision Hip and Knee Arthroplasty Using Modern Perioperative Protocols

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Safety of Same and Next Day Discharge Following Revision Hip and Knee Arthroplasty Using Modern Perioperative Protocols Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Safety of Same and Next Day Discharge Following Revision Hip and Knee Arthroplasty Using Modern Perioperative Protocols
Creator	Buller, Leonard Ziemba-Davis, Mary Deckard, Evan Hubbard, Trey Bse, Deckard Meneghini, R
Source	Elsevier; Medline; PMC
abstract	INTRODUCTION: Advances in perioperative care have enabled early discharge and outpatient primary total joint arthroplasty (TJA). However, the safety of early discharge after revision TJA (rTJA) remains unknown and the COVID-19 pandemic will force decreased hospitalization. This study compared 90-day outcomes in patients undergoing aseptic rTJA discharged the same or next day (early) to those discharged two or three days postoperatively (later). METHODS: 530 aseptic rTJAs performed at a single tertiary referral center (12/5/2011-12/30/2019) were identified. Early and later discharge patients were matched as closely as possible on procedure type, sex, ASA-PS classification, age, and BMI. All patients were optimized using modern perioperative protocols. The rate of 90-day ED visits and hospital admissions was compared between groups. RESULTS: 183 early discharge rTJAs (54 hips, 129 knees) in 178 patients were matched to 183 later discharge rTJAs (71 hips, 112 knees) in 165 patients. 62% of the sample was female, with an overall average age and BMI of 63±9.9 (range: 18-92) years and 32±6.9 (range: 18-58) kg/m(2). There was no statistical difference in 90-day ED visit rates between early (6/178, 3.4%) and later (11/165, 6.7%) discharge patients (p=0.214). 90-day hospital admission rates for early (7/178, 3.9%) and later (4/165, 2.4%) did not differ (p=0.545) CONCLUSIONS: Using modern perioperative protocols and with appropriate patient selection, early discharge following aseptic rTJA does not increase 90-day readmissions or ED visits. As hospital inpatient capacity remains limited due to COVID-19, select rTJA patients may discharge home the same or next day to preserve hospital beds and resources for more critical medically related illness.
has issue date	2020-07-30(xsd:dateTime)
bibo:doi	10.1016/j.arth.2020.07.062
bibo:pmid	32839058
has license	no-cc
sha1sum (hex)	5840ebdf814467d914b84af7aade7b16132016c6
schema:url	https://doi.org/10.1016/j.arth.2020.07.062
resource representing a document's title	Safety of Same and Next Day Discharge Following Revision Hip and Knee Arthroplasty Using Modern Perioperative Protocols
has PubMed Central identifier	PMC7391218
has PubMed identifier	32839058
schema:publication	J Arthroplasty
resource representing a document's body	covid:5840ebdf814467d914b84af7aade7b16132016c6#body_text
is schema:about of	named entity 'Arthroplasty' named entity 'Running' named entity 'Hip' named entity 'Revision' named entity 'Next' named entity 'Modern' named entity 'chemoprophylaxis' named entity 'Discharge' named entity 'Day' named entity 'Knee' named entity 'Perioperative' named entity 'Arthroplasty' named entity 'Demographic' named entity 'Postoperative Pain' named entity 'aseptic' named entity 'inpatient care' named entity 'total knee arthroplasty' named entity 'perioperative period' named entity 'hydromorphone' named entity 'celecoxib' named entity 'etiologies' named entity 'perioperative' named entity 'multidisciplinary approach' named entity 'not-for-profit' named entity 'aseptic' named entity 'long-term' named entity 'aseptic' named entity 'thromboembolism' named entity 'pregabalin' named entity 'contraindicated' named entity 'etiologies' named entity 'medical specialist' named entity 'perioperative care' named entity 'pain management' named entity 'oxycodone' named entity 'arthroplasty' named entity 'joint replacement' named entity 'aseptic' named entity 'allergic' named entity 'antibiotics' named entity 'physical therapy' named entity 'multidisciplinary team' named entity 'severe pain' named entity 'aseptic' named entity 'aseptic' named entity 'perioperative' named entity 'Outpatient' named entity 'acetaminophen' named entity 'perioperative care' named entity 'arthroplasty' named entity 'aspirin' named entity 'multidisciplinary approach' named entity 'infection' named entity 'Perioperative' named entity 'multidisciplinary approach' named entity 'inpatient care' named entity 'long-term' named entity 'multidisciplinary approach' named entity 'allergic rash' named entity 'patient safety' named entity 'total hip arthroplasty' named entity 'surgical technique' named entity 'Patient Care' named entity 'Thromboprophylaxis' named entity 'patient care' named entity 'Postoperative pain' named entity 'perioperative' named entity 'intravenous' named entity 'aseptic' named entity 'pain control' named entity 'risk assessment' named entity 'patient care' named entity 'multidisciplinary' named entity 'oxycodone' named entity 'enteric coated' named entity 'Anesthesia'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software